Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group

Diabetes and Metabolism

Volumn 25, Issue 4, 1999, Pages 334-340

  Schiel, R ^a   Muller U A ^b   Rauchfub, J ^b   Sprott, H ^b   Muller R ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b NONE

Author keywords

Blood glucose self monitoring; Conventional insulin therapy; Hypoglycaemia; Structured treatment and teaching programme; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETES CONTROL; FEMALE; HEALTH CARE QUALITY; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE SELF-MONITORING; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERVENTION STUDIES; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 0345425737     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
2. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications trial. Diabetes, 1996, 45, 1289-1298.
3. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Int Med, 1991, 230, 101-108.
4. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med, 1993, 329, 304-309.
5. Reichard P, Pihl M, Rosenqvist U, Sule J. Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow-up. Diabetologia, 1996, 39, 1483-1488.
6. Holman RR, Mayon-White V, Orde-Peckar C et al. Prevention of deterioration of renal and sensory nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomized prospective study. Lancet, 1983, I, 204-208.
7. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: An update of the Steno studies. Diabetologia, 1991, 34, 164-170.
8. Dahl-Jörgensen K, Hanssen KF, Kierulf P, Björo T, Sandvik L, Aagenaes Ö. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus: The Oslo study. Acta Endocrin, 1988, 117, 19-25.
9. The Kroc Collaborative Study Group. Diabetic retinopathy after two years of intensified insulin treatment. J Am Med Assoc, 1988, 260, 37-41.
10. Brinchmann-Hansen O, Dahl-Jörgensen K, Sandvik L, Hanssen KF. Blood glucose concentrations and progression of diabetic retinopathy: The seven years results of the Oslo study. Br Med J, 1992, 304, 19-22.
11. Abraira C, Colwell JA, Nuttall FQ et al. and the VA CSDM Group. Veterans affairs cooperative study on glycemic control and complications in type II diabetes. Diabetes Care, 1995, 18, 1113-1123.
12. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diab Res Clin Pract, 1995, 28, 103-117.
13. Alberti KGMM, Gries FA, Jervell J, Krans for the European NIDDM Policy Group. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): An update. Diab Med, 1994, 11, 899-909.
14. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care, 1994, 17, 1514-1522.
15. Henry RR, Genuth S. Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med, 1996, 124, 175-177.
16. UK prospective diabetes study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-853.
17. Newman WP, Laqua D, Engelbrecht D. Impact of glucose self-monitoring on glycohemoglobin values in a veteran population. Arch Intern Med, 1990, 150, 107-110.
18. Tattersall R. Self monitoring of blood glucose concentrations by non-insulin dependent diabetic patients. Of unproved value and often done badly. Br Med J, 1992, 305, 1171-1172.
19. Patrick AW, Gill GV, MacFarlane IA, Cullen A, Power E, Wallymahmed M. Home glucose monitoring in type 2 diabetes: Is it a waste of time? Diabetic Med, 1994, 11, 62-65.
20. Nathan DM, McKitrick C, Larkin M, Schaffran R, Singer DE. Glycemic control in diabetes mellitus: Have changes in therapy made a difference? Am J Med, 1996, 100, 157-163.
21. Gallichan M. Self monitoring of glucose by people with diabetes: evidence based practice. Br Med J, 1997, 314, 964-967.
22. American Diabetes Association. Tests of glycemia in diabetes. Diab Care, 1997, 20, S18-S20.
23. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997, 20, 1183-1197.
24. Schiel R, Müller UA, Sprott H et al. The JEVIN-trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990. Diabetologia, 1997, 40, 1350-1357.
25. Kademann A, Schiel R, Müller UA. Intensive or conventional insulin therapy in type 2 diabetes. (Abstract) Diabetologia, 1998, 41, A249.
26. Müller UA, Femerling M, Reinauer KM et al. for the ASD (The working group on structured diabetes therapy of the German diabetes association): Intensified treatment and education of type 1 diabetes as clinical routine: A nationwide quality-circle experience in Germany. Diabetes Care, 1999, 22, B29-B34.
27. Berger M, Bott U, Grüßer M et al. Behandlungs-und Schulungsprogramm für Typ-II-Diabetiker, die Insulin spritzen. Deutscher Arzte-Verlag, Cologne, Germany, 1990
28. Müller UA, Müller R, Starrach A, Jörgens V, Grüßer M. Optimierung der Insulintherapie bei Patienten mit Diabetes mellitus Typ-2 in der Arztpraxis. Diab Stoffw, 1998, 7, 116.
29. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care, 1997, 20, 1482-1486.
30. Harris MI, Cowie C, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care, 1993, 16, 1116-1123.
31. Mühlhauser I, Jörgens V, Berger M et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: Improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia, 1983, 25, 470-476.
32. Mühlhauser I, Bruckner I, Berger M et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia, 1987, 30, 861-890.
33. Jörgens V, Grüßer M, Bott U, Mühlhauser I, Berger M. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia, 1993, 36, 99-105.
34. Müller UA, Hunger-Dathe W, Kobes M, Reuber E, Kirchner D. Qualität der Stoffwechseleinstellung bei Typ-1-Diabetikern ein Jahr nach Teilnahme an einem strukturierten Behandlungsprogramm für intensivierte konventionelle Insulintherapie. Diab Stoffw, 1995, 4, 9-13.
35. Schiel R, Müller UA, Ulbrich S. Long-term efficacy of a 5-day structured teaching and treatment programme for intensified conventional insulin therapy and risk for severe hypoglycemia. Diab Res Clin Pract, 1997, 35, 41-48.
36. Mühlhauser I, Heinemann L, Karinganamattom J, Schuwirth W, Berger M. Accuracy of blood glucose self monitoring in elderly insulin treated diabetic patients. Diabetes Metab, 1991, 17, 476-482.
37. Sawicki PT, Karschny L, Stolpe V, Wolf E, Berger M. Color discrimination and accuracy of blood glucose self-monitoring in type I diabetic patients. Diabetes Care, 1991, 14, 135-137.
38. Trajanoski Z, Brunner G, Gferer RJ, Wach P, Pieber TR. Accuracy of home blood glucose meters during hypoglycemia. Diabetes Care, 1996, 19, 1412-1415.
39. Heinemann L, Overmann H, Mühlhauser I. Qualität der Blutglukoseselbstmessung von 636 Patienten mit Typ-I-Diabetes mellitus. Diab Stoffw, 1997, 6, 59-63.
40. Schiel R, Drewelow S, Martin C et al. Präzision und Richtigkeit häufig benutzter Taschenreflektometer zur Blutzuckerschnellbestimmung: One Touch Basic, One Touch II, One Touch Profile und Gluco Touch. Diab Stoffw, 1998, 7, 86-90.